Purpose/Objective: Pneumonitis is a dose limiting side effect induced by radiotherapy for any thorax associated neoplasms. For example, pneumonitis can cause symptoms of respiratory failure and results in a lethality rate up to 10 %. Currently, the underlying mechanisms for irradiation induced pneumonitis are not known in detail. Although pneumonitis mostly occurs within irradiated areas of the lung, it may spread to non irradiated areas, indicating that humoral factors may be involved. In parallel to its role in apoptosis induction, the CD95/CD95-L system mediates proinflammatory cytokine responses and attracts neutrophils. It is currently hypothetical that complex alterations of cytokine expression patterns in combination with infectious triggers are of major importance for the induction of pneumonitis. In this regard it has been shown that bacterial infection results in increased CD95/CD95 ligand surface expression and induction of apoptosis and secondly leads to secretion of defensins and cytokines. Furthermore, bleomycin-mediated pneumonitis was significantly diminuated after administration of CD95 antigen or anti CD95 ligand antibody. Since the expression of CD95 and CD95-Ligand (CD95-L) is known to be induced by ionizing irradiation, we investigated if the CD95 system is involved in the pathology of irradiation induced pneumonitis. For this reason, genetic defined mice with a deficiency of the CD95 receptor (lpr), deficiency of the ligand (gld) and control mice with an intact CD95 system (C57BL6/J) were examined on the development of pneumonitis after irradiation. Materials/Methods: Female C57Bl/6J, lpr and gld mice were acclimated to a total-body plethysmograph for a minimum of 2 weeks and enrolled to the research protocol with a body weight of 20g. To evaluate the dysfunction of the lung in pneumonitis, after single irradiation of the right hemithorax with doses of 0/12,5Gy, the breathing frequency was determined twice weekly for the following 30 weeks. Histopathological alterations judged by alveolar wall thickness, interstitial edema, interstitial and peribronchial inflammation were analyzed at days 1, 21, 42, 84 and d210 by using the hematoxyllin-eosine staining. For each of the morphologic alterations noted above, a numerical score was determined. Criteria for scoring for each lesion were assessed as follows: 0 < 10% of the fields viewed; 1= 10–30%; 2= 30–50%; 3= 50–70%; 4≥70% and the cumulative inflammation score was determined. Results: Whereas a highly significant increase of breathing frequency occurred in control mice between days 5–70, no such increase was detectable in gld and lpr mice. Furthermore, no inflammatory response with increasing alveolar wall thickness, interstitial edema, increasing number of inflammatory cells in the interstitial and peribronchial space was neither detected in lpr and gld mice. In contrast, in control mice, a clear inflammatory response was visible (right lung > left lung) with a peak between day 21–42. Conclusions: These results suggest that the CD95/CD95 (Fas-Fas ligand) pathway plays an essential role in the development of pneumonitis. The identification of the CD95/CD95-L-system may offer new options for preventing or treating radiation induced pneumonitis.